132 related articles for article (PubMed ID: 36189275)
1. A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma.
Li J; Liu X; Qi Y; Liu Y; Du E; Zhang Z
Front Immunol; 2022; 13():922929. PubMed ID: 36189275
[TBL] [Abstract][Full Text] [Related]
2. The Necroptotic Process-Related Signature Predicts Immune Infiltration and Drug Sensitivity in Kidney Renal Papillary Cell Carcinoma.
Lin W; Xue R; Ueki H; Huang P
Curr Cancer Drug Targets; 2024 Apr; ():. PubMed ID: 38616744
[TBL] [Abstract][Full Text] [Related]
3. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
Hong Y; Lin M; Ou D; Huang Z; Shen P
BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma.
Tang H; Chen H; Yuan H; Jin X; Chen G
Transl Cancer Res; 2022 Dec; 11(12):4254-4271. PubMed ID: 36644185
[TBL] [Abstract][Full Text] [Related]
5. A polyamine metabolism risk signature for predicting the prognosis and immune therapeutic response of kidney cancer.
Li B; Kong Z; Liu Y; Xu B; Liu X; Li S; Zhang Z
Transl Cancer Res; 2023 Oct; 12(10):2477-2492. PubMed ID: 37969387
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
Chen X; Zhang Z; Qin Z; Zhu X; Wang K; Kang L; Li C; Wang H
Aging (Albany NY); 2024 Mar; 16(6):5676-5702. PubMed ID: 38517387
[TBL] [Abstract][Full Text] [Related]
7. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
[TBL] [Abstract][Full Text] [Related]
8. Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction.
Tai R; Leng J; Li W; Wu Y; Yang J
BMC Urol; 2023 Sep; 23(1):147. PubMed ID: 37715154
[TBL] [Abstract][Full Text] [Related]
9. Lipid metabolism-related gene expression in the immune microenvironment predicts prognostic outcomes in renal cell carcinoma.
Zhang Q; Lin B; Chen H; Ye Y; Huang Y; Chen Z; Li J
Front Immunol; 2023; 14():1324205. PubMed ID: 38090559
[TBL] [Abstract][Full Text] [Related]
10. A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma.
Lu Q; Xi P; Xu S; Zhang Z; Gong B; Liu J; Zhu Q; Sun T; Zhu S; Chen R
Aging (Albany NY); 2024 Mar; 16(7):6118-6134. PubMed ID: 38546385
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma.
Wei K; Zhang X; Yang D
PeerJ; 2023; 11():e16643. PubMed ID: 38130918
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma.
Chen J; Zhang D; Ren X; Wang P
Aging (Albany NY); 2023 Oct; 15(20):11012-11032. PubMed ID: 37847171
[TBL] [Abstract][Full Text] [Related]
13. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma.
Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A
Front Oncol; 2022; 12():941156. PubMed ID: 36505813
[TBL] [Abstract][Full Text] [Related]
14. Glutathione peroxidase family and survival prognosis in patients with renal cell carcinoma.
Li J; Huo S; Zhang R; Shi C; Sun N; Liu Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):562-572. PubMed ID: 35753726
[TBL] [Abstract][Full Text] [Related]
15. Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma.
Luo G; Wang L; Zheng Z; Gao B; Lei C
Eur J Med Res; 2023 May; 28(1):176. PubMed ID: 37189176
[TBL] [Abstract][Full Text] [Related]
16. Construction of exosome-related genes risk model in kidney cell carcinoma predicts prognosis and immune therapy response.
Gao C; Huang W; Su Q; Li J; Wang W; Qi Y; Du E; Zhang Z
Aging (Albany NY); 2024 May; 16():. PubMed ID: 38728235
[TBL] [Abstract][Full Text] [Related]
17. A 14 immune-related gene signature predicts clinical outcomes of kidney renal clear cell carcinoma.
Zou Y; Hu C
PeerJ; 2020; 8():e10183. PubMed ID: 33194402
[TBL] [Abstract][Full Text] [Related]
18. Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
Ji D; Zhong R; Fan S
Biomed Res Int; 2022; 2022():8740408. PubMed ID: 35647181
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a Seven-Gene Signature Associated with CD8
Chen Y; Zhou X; Xie Y; Wu J; Li T; Yu T; Pang Y; Du W
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762031
[TBL] [Abstract][Full Text] [Related]
20. Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma.
Jiang S; Dong Y; Wang J; Zhang X; Liu W; Wei Y; Zhou H; Shen L; Yang J; Zhu Q
Front Immunol; 2023; 14():1207061. PubMed ID: 37662929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
